Skip to main content
. 2016 Sep 1;27(9):700–711. doi: 10.1089/hum.2016.038

Table 1.

Data collection schedule for the safety study of alphavirus M1

  Study day
Procedure 0 1 2 3 4 5 6 7 13 21 28 32 39 46 53 60 67 74 81 88 95 105
Body weight ×         ×     × ×   × × × × × × × × × × ×
Temperature × × × × × × × × × × × × × × × × × × × × × ×
Clinical observation × × × × × × × × × × × × × × × × × × × × × ×
Hematology ×   ×   × × × × × × ×   × × × × × × × × ×  
Blood biochemistry ×         ×     × × ×   × × × × × × × × ×  
Cytokine × × × ×       × × × × × × × × × × × × × ×  
Urine ×               × × ×   × × × × × × × × ×  
M1 titration (blood)   × × × ×                                  
qRT-PCR (blood)   × × × ×                                  
Neutralization assay ×     ×           ×                     ×  

M1, oncolyticvirus M1; qRT-PCR, quantitative real-time polymerase chain reaction.